SCO-267 is under development for the treatment of non-alcoholic steatohepatitis (NASH), diabetes, nonalcoholic fatty liver disease and obesity. It acts by targeting GPR40. It is administered through ...
By Jamie Mayes Click here for updates on this story SALEM, Indiana (WLKY) — On Christmas morning, while many children eagerly anticipate unwrapping the latest toys and gadgets. Seth Heninger is ...
Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...
The event Reddy referred to is a hypothetical phenomenon called Kessler Syndrome. Named for American astrophysicist Donald Kessler and based on his 1978 academic paper, Kessler Syndrome — as the ...
Two mechanisms have been proposed as causes: syndrome of inappropriate anti-diuretic hormone and cerebral salt wasting. Physical examination and laboratory results can assist a clinician in ...